Literature DB >> 7196787

Dopamine-like properties of ephedrine in rat brain.

M R Zarrindast.   

Abstract

1 Ephedrine (3.1-50 mg/kg) was given intraperitoneally to rats and was found to cause a marked increase in spontaneous locomotor activity. 2 In rats with a unilateral lesion in the substantia nigra made by stereotaxic injections of 6-hydroxydopamine, ephedrine (12.5-150 mg/kg i.p.) caused a dose-dependent turning towards the lesioned side. 3 Turning behaviour and increase in locomotion produced by ephedrine were antagonized by pretreatment of the animals with pimozide, amino-oxyacetic acid or reserpine plus alpha-methyl-p-tyrosine, but not by pretreatment with phenoxybenzamine, propranolol or methergoline. 4 In in vitro studies with synaptosomes prepared from rat brain, ephedrine blocked the uptake and caused the release of [3H]-dopamine. 5 Similar results with regard to locomotion and turning behaviour were obtained with (+)-amphetamine. 6 It is concluded that the increase in locomotion and turning behaviour produced by ephedrine is mediated through an indirect dopaminergic mechanism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7196787      PMCID: PMC2071871          DOI: 10.1111/j.1476-5381.1981.tb09962.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs.

Authors:  K Fuxe; T Hökfelt; A Ljungdahl; L Agnati; O Johansson; M Perez de la Mora
Journal:  Med Biol       Date:  1975-06

2.  Drugs, neurotransmitters, and schizophrenia.

Authors:  S H Snyder; S P Banerjee; H I Yamamura; D Greenberg
Journal:  Science       Date:  1974-06-21       Impact factor: 47.728

3.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

4.  Psychosis accompanying use of bronchodilator compound.

Authors:  F J Kane; R Florenzano
Journal:  JAMA       Date:  1971-03-29       Impact factor: 56.272

5.  Ephedrine psychosis.

Authors:  C F Herridge; M F a'Brook
Journal:  Br Med J       Date:  1968-04-20

6.  Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep".

Authors:  R H Roth; Y Suhr
Journal:  Biochem Pharmacol       Date:  1970-12       Impact factor: 5.858

7.  GABA blockade, dopamine and schizophrenia: experimental studies in the cat.

Authors:  J Stevens; K Wilson; W Foote
Journal:  Psychopharmacologia       Date:  1974

8.  Studies on the GABA pathway. I. The inhibition of gamma-aminobutyric acid-alpha-ketoglutaric acid transaminase in vitro and in vivo by U-7524 (amino-oxyacetic acid).

Authors:  D P WALLACH
Journal:  Biochem Pharmacol       Date:  1961-02       Impact factor: 5.858

9.  Mazindol anorexia is mediated by activation of dopaminergic mechanisms.

Authors:  Z L Kruk; M R Zarrindast
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

10.  Dopaminergic agonist properties of ephedrine--theoretical implications.

Authors:  B Angrist; J Rotrosen; D Kleinberg; V Merriam; S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1977-12-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.